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Abstract 
Intestinal health is critically important for the welfare and performance of poultry. Enteric diseases that cause gut bar-
rier failure result in high economic losses. Up till now there is no reliable faecal marker to measure gut barrier failure 
under field conditions. Therefore, the aim of the present study was to identify a faecal protein marker for diminished 
intestinal barrier function due to enteric diseases in broilers. To assess this, experimental necrotic enteritis and coc-
cidiosis in broilers were used as models for gut barrier failure. Ovotransferrin was identified as a marker for gut barrier 
failure using a proteomics approach on samples from chickens with necrotic enteritis. These results were confirmed 
via ELISA on samples derived from both necrotic enteritis and coccidiosis trials, where faecal ovotransferrin levels were 
significantly correlated with the severity of gut barrier failure caused by either coccidiosis or necrotic enteritis. This 
indicates that faecal ovotransferrin quantification may represent a valuable tool to measure gut barrier failure caused 
by enteric pathogens.
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Introduction
Intestinal health is critically important for the welfare 
and performance of poultry. Enteric diseases that affect 
the structural integrity of the gastrointestinal tract lead 
to high economic losses due to reduced weight gain, 
poor feed conversion efficiency, increased mortality 
rates and greater medication costs [1, 2]. Coccidiosis 
and necrotic enteritis (NE) probably are the most com-
mon enteric diseases of poultry [3, 4]. In poultry, coccidi-
osis can be caused by multiple species belonging to the 
genus Eimeria, of which Eimeria acervulina, E. maxima 
and E. tenella are the most common species in inten-
sively reared broilers. Lesions are found in the intestines 
at a specific place for each Eimeria species. In chickens, 
E. acervulina typically infects the duodenum, whereas E. 
maxima infects both the duodenum and jejunum and E. 
tenella infects the caecum [5, 6]. Depending on the spe-
cies, the lesions can range from a limited malabsorptive 
enteritis (E. acervuline) to more severe inflammation of 
the intestinal wall (E. maxima) and even extensive cae-
cal haemorrhage, leading to mortality (E. tenella) [7]. 
Furthermore, the presence of Eimeria species can also 
exacerbate the outcome of co-infection with bacterial 
pathogens such as Clostridium perfringens [8]. Indeed, 
the mucosal damage caused by these coccidial pathogens 
is an important predisposing factor for necrotic enteri-
tis (NE) [3]. NE is the most common clostridial enteric 
disease in poultry, which typically occurs in broilers. The 
disease is caused by C. perfringens and can occur either 
in an acute clinical or as a mild subclinical form. Acute 
NE typically leads to a massive increase in flock mortality. 
The more common subclinical form is characterized by 
multifocal necrosis and inflammation of the small intes-
tine with a significant decline in growth performance [1]. 
The reduction in performance is not only associated with 
impaired growth rate and feed conversion, but also with 
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increased condemnation rates in broilers due to hepatitis 
at processing [9].
Both coccidiosis and necrotic enteritis can be present 
in a flock without clinical signs. Therefore, multiple birds 
have to be sacrificed for macroscopic examination of the 
intestine to diagnose disease. A faecal marker, or a set 
of markers, that can accurately detect intestinal inflam-
mation and concomitant perturbation of the intestinal 
integrity at an early stage would be useful. Recently, there 
has been increased interest in research on intestinal per-
meability in chickens, resulting in different strategies to 
measure intestinal inflammation and concomitant gut 
barrier failure. However, none of the proposed measure-
ments can be used as a marker for intestinal inflamma-
tion and barrier failure under field conditions as they are 
not easy to apply. The reasons are the requirement to use 
invasive techniques (e.g. oral administration of a marker 
that can be measured in the blood on a later timepoint 
[10, 11]) or the non-gut-specific nature of the markers 
(e.g. serum markers that can be elevated by non-gastroin-
testinal conditions as well [12–14]). Faecal markers may 
be more accurate in determining gastrointestinal inflam-
mation and gut barrier failure [15]. The aim of this study 
was to identify a faecal protein marker for the detection 
of intestinal barrier damage and inflammation in broiler 
chickens. Therefore, proteome analysis was performed on 
faecal samples derived from animals under experimental 
necrotic enteritis challenge. The identified biomarker was 
validated using faecal and litter samples from birds with 
experimental necrotic enteritis or coccidiosis.
Materials and methods
Animal trials and sample collection
The experiments were approved by the ethical committee 
of the Faculty of Veterinary Medicine, Ghent University 
(NE trials; EC2013/180, EC2013/181 and EC2015/91) or 
the ethical committee of Poulpharm Bvba, Izegem, Bel-
gium (coccidiosis trial; EC 201503). All animal experi-
ments were carried out in accordance with the approved 
guidelines.
Necrotic enteritis trials
An in  vivo subclinical necrotic enteritis model based 
on previous studies was used [16]. Briefly, groups of 27 
1-day-old Ross 308 broiler chickens were fed a diet rich 
in proteins and non-starch polysaccharides which predis-
pose to the development of necrotic enteritis. A detailed 
diet composition was described elsewhere [16]. Other 
predisposing factors included the administration of 
Gumboro vaccine (either Nobilis Gumboro D78 (MSD 
Animal Health, Kempton Park, South Africa) or Poulvac 
Bursa Plus (Zoetis, New Jersey, USA), depending on the 
trial) to induce mild immunosuppression, and a tenfold 
dose of coccidiosis vaccine (either Paracox-8 (MSD Ani-
mal Health) or Hipracox (Hipra, Girona, Spain), depend-
ing on the trial) to induce predisposing intestinal 
damage. To induce necrotic lesions, animals were orally 
challenged with approximately 4 × 108 CFU C. perfrin-
gens strain CP56 on 3 consecutive days, after which the 
animals were euthanized. At necropsy, lesion scoring in 
the small intestine (duodenum, jejunum and ileum) was 
performed as described by Gholamiandehkordi et al. [16] 
as follows: score 0 = no lesions, score 1 = congested intes-
tinal mucosa, score 2 = focal necrosis or ulcerations (1–5 
foci), score 3 = focal necrosis or ulcerations (6–15 foci), 
score 4 = focal necrosis or ulcerations (≥ 16 foci), score 
5 = patches of necrosis of 2–3 cm long, score 6 = diffuse 
necrosis. Birds with a lesion score of 2 or more are clas-
sified as necrotic enteritis positive. In this study, samples 
were collected from three independent necrotic enteritis 
in vivo trials. From each trial, fresh distal colon content 
(further referred to as faecal samples) was collected from 
all birds and frozen at −70 °C. Samples from the first two 
trials were used for proteome analysis (see below). Sam-
ples from a third trial were used to validate the proteome 
results using ELISA (see below). From this third trial, also 
mixed litter was collected from each pen. After lesion 
scoring, the samples were grouped according to the dis-
ease severity of the animal, leading to the following dis-
ease severity groups: birds that received all predisposing 
factors but were not challenged with C. perfringens: nega-
tive control; birds challenged with C. perfringens but no 
necrosis: score 0 or challenged with C. perfringens and 
various severity degrees: score 2 (mild), score 3–4 (mod-
erate) or score 5–6 (severe).
Coccidiosis trial
Four hundred one-day-old Ross 308 broiler chickens 
were randomly allocated into groups of 20 birds and fed 
a standard broiler feed free from antibiotics and anticoc-
cidials. To induce coccidiosis, 10 groups of chicks were 
inoculated orally with 15 × 104 oocysts of E. acervulina, 
4.6 × 104 oocysts of E. tenella, 2 × 104 oocysts of E. 
maxima and 1 × 104 oocysts of E. brunetti at the age of 
15 days. The birds in the other 10 groups remained unin-
fected and served as age-matched controls. Seven days 
after challenge, three chickens per group were euthanized 
for lesion scoring using the method of Johnson and Reid 
[17] and fresh distal colon content (further referred to as 
faecal samples) was collected. On the same day, one pool 
of fresh litter sample was collected from each group. All 
challenged birds showed macroscopically visible lesions 
of Eimeria infection, with a mean coccidiosis score of 
5.11 ± 0.51, whereas only one out of 10 birds in the non-
challenged control group was coccidiosis positive (coc-
cidiosis score = 1). All samples were stored at −70 °C.
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Proteomic analysis of faecal samples from the necrotic 
enteritis in vivo trials
To identify protein markers that could be used as a bio-
marker for sub-clinical necrotic enteritis, five samples 
obtained from birds that were inoculated with C. perfrin-
gens and had a lesion score of 3–4 (moderate NE severity) 
were compared to five samples obtained from birds that 
received all predisposing factors but were not inoculated 
with C. perfringens.
Sample preparation
Samples were prepared based on a previously described 
method for human stool samples, with some adapta-
tions for chicken faeces [18]. Unprocessed faeces were 
thawed at room temperature. Approximately 0.5 g sample 
(wet content) was weighed and extraction buffer [50 mM 
Tris–HCl, 10  mM  CaCl2, pH 7.8 and protease inhibitor 
cocktail (Roche Diagnostics Corporation, Indianapolis, 
USA)] was added till 10  mL. Samples were vortexed 10 
times for 10  s, followed by a low-speed centrifugation 
step (10  min, 4  °C, 800  ×  g) to remove large particles. 
The supernatant was transferred and the extraction was 
repeated twice.
Bacterial cells were lysed by sonication of the superna-
tants using a Barnson Digital Sonifier Model 250-D oper-
ating at an amplitude of 30% and a 1 s on, 1 s off cycle for 
1  min. Subsequently the samples were cleared by high-
speed centrifugation (10 min, 4 °C, 6000 × g) to remove 
cell debris.
After filtration (0.22  µm filter) the proteins were pre-
cipitated using 10% tri-chloro acetic acid (TCA) over-
night at 4 °C. The precipitated proteins were collected by 
centrifugation (30 min, 4 °C, 16 000 × g). The pellets were 
resuspended in 1 mL of extraction buffer, and transferred 
to a 10-kDa cut-off ultracentrifugation membrane filter 
tube (Amicon, Merck Millipore, Darmstadt, Germany). 
The proteins were washed with a minimum of 20  mL 
extraction buffer and concentrated until 0.5 mL.
1D gel electrophoresis and LC–MS/MS 
measurements
Protein concentration was measured by Bradford assay 
and 15  µg of protein solution was mixed with Laem-
lli buffer (62.5 mM Tris–HCl (pH 6.8), 10% glycerol, 1% 
SDS, 5% β-mercaptoethanol and 0.001% bromophenol 
blue). After boiling for 10 min, the reduced sample was 
loaded on a 1D SDS-PAGE gel. The molecular weight 
(MW) marker (Precision Plus Protein Standards, Bio-
Rad, Nazareth Eke, Belgium) was loaded as reference to 
cut the lanes in five bands. The proteins were electro-
mobilised at 150  V, the gel was then fixed and stained 
overnight with Coomassie brilliant blue G-250. After 
destaining in 30% methanol to obtain a clear back-
ground, the reduced and alkylated gel was sliced into 
five bands per lane. Each band was in-gel digested with 
trypsin and analysed via a fully automated LC MS/MS 
setup [19]. Briefly, 4 µL of a peptide solution was initially 
concentrated and desalted on a Zorbax 300SB-C18 trap-
ping column (5 mm × 0.3 mm, Agilent, Santa Clara, CA, 
USA) at a 4  µL/min flow rate using a 2% (v/v) acetoni-
trile, 0.1% formic acid in water. After valve switching, 
the peptides were injected to and separated on a Zorbax 
300SB-C18 analytical column, 150  mm × 75  µm (Agi-
lent, Santa Clara, CA, USA), by a 30 min linear gradient 
ranging from 2% (v/v) to 50% (v/v) acetonitrile, 0.1% for-
mic acid in water at a 300 nL/min flow rate. The eluting 
peptides were measured online on a LTQ-FT Ultra mass 
spectrometer (Thermo Fisher Scientific, Waltham, MA, 
USA). The FT-ICR mass analyser acquired MS scans at 
a resolution of 100  000 during the LC separation. The 
five most abundant molecular ions from each MS scan 
were automatically selected by the LTQ ion trap mass 
analyser. Subsequently, the precursor ions (charge state 
+ 1 is rejected) were fragmented by collision-induced 
dissociation (CID), using normalised collision energy of 
35.0%. After two occurrences, the precursor masses were 
excluded for 90 s.
Protein identification
Peak detection from raw data was performed by Extract-
MSn version 1.0.0.8 (Thermo, default parameters), 
which determines the monoisotopic m/z ratio value and 
charged status of the precursor ions along with the m/z 
values and the intensities of the fragment ions. Mascot 
Daemon (Matrix Science, London, UK; version 2.4.1) 
was used to search the retrieved peak list against the 
NCBI non-redundant protein database. Search param-
eters were assuming the digestion enzyme trypsin with a 
fragment ion mass tolerance of 0.3 Da, and a parent ion 
tolerance of 10  ppm. Oxidation of methionine and car-
bamidomethylation of cysteine were specified as variable 
modifications.
The resulting Mascot DAT-files were loaded in Scaffold 
(Proteome Software Inc., Portland, OR, version 4.4.1) and 
the MS/MS data were analysed using X! Tandem (The 
GPM, thegpm.org; version CYCLONE 2010.12.01.1). X! 
Tandem was set up to search a subset of the reverse con-
catenated database using the same parameters as Mascot, 
but glutamate and glutamine to PyroGlu and ammonia-
loss of the N-terminus and oxidation of methionine and 
carbamidomethylation of cysteine were specified as vari-
able modifications. Scaffold was used to validate MS/MS 
based peptide and protein identifications.
The peptide identifications were accepted if they could 
be established at higher than 99.0% probability by the 
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Scaffold Local FDR algorithm. Protein identifications 
were accepted if they could be established at greater 
than 99.9% probability and contained at least two identi-
fied peptides. Protein probabilities were assigned by the 
ProteinProphet algorithm [20]. Proteins that contained 
similar peptides and could not be differentiated based on 
MS/MS analysis alone were grouped to satisfy the prin-
ciples of parsimony. Proteins sharing significant peptide 
evidence were grouped into protein clusters. Quantifi-
cation was based on exclusive spectral counting, a label 
free proteomics approach were the frequency of collect-
ing a peptide precursor ion in MS/MS is used as a quan-
titative measure [21]. Spectral counts were normalized to 
the total number of spectra in the corresponding LC–MS 
run.
Ovotransferrin detection by enzyme‑linked 
immunosorbent assay (ELISA)
In order to confirm the ovotransferrin results obtained 
from the proteomic analysis of faecal samples from the 
necrotic enteritis in  vivo trials, faecal samples from 
another, independent, necrotic enteritis in vivo trial were 
used. Eight samples from the non-challenged control 
birds (receiving all predisposing factors, but  not chal-
lenged with C. perfringens) and eight samples per necro-
sis score group (either mild, moderate or severe NE) 
from challenged birds were selected. Also litter samples 
collected at the day of necropsy were included (one lit-
ter sample per pen, with in total three samples from pens 
with non-challenged birds and three samples from pens 
with challenged birds). Additionally, the ovotransferrin 
concentration was determined in both faecal samples and 
litter samples derived from the coccidiosis trial. There-
fore, 5 litter samples from pens with non-challenged 
birds and 6 litter samples from pens with Eimeria-chal-
lenged birds were used. Additionally, 20 faecal samples 
from either Eimeria-challenged birds (n = 10, one sam-
ple from each group) or their non-challenged controls 
(n = 10, one sample from each group) were selected.
Unprocessed faeces or homogenized litter material 
were thawed at room temperature. The faeces or litter 
material (150  mg) was diluted in 1500  µL TBS (50  mM 
Tris, 150  mM NaCl, pH = 7.2) with protease inhibitor 
cocktail (P2714, Sigma-Aldrich). The samples were mixed 
by vortex (2 × 1  min). Proteins (supernatants) were col-
lected after centrifugation (13  000  ×  g, 10  min, 4  °C) 
and were used in duplicate (1/50 dilution) in the ELISA 
(Chicken Ovotransferrin ELISA, KT-530, Kamiya Bio-
medical Company, Tukwila, USA). The ELISA was per-
formed according to the instructions of the manufacturer.
Ovotransferrin stability in faecal material
To assess the stability of ovotransferrin in chicken faeces, 
ovotransferrin (Conalbumin, Sigma-Aldrich) was spiked 
in two faecal samples from different birds to obtain a 
final concentration of 200  µg ovotransferrin per gram 
faeces. The spiked samples were aliquoted and incubated 
at room temperature for 0, 1, 6 or 24  h, proteins were 
extracted as described above and used in duplicate (1/50 
dilution) on the chicken Ovotransferrin ELISA.
In order to elucidate whether the observed decline in 
ovotransferrin signal is due to proteolysis caused by pro-
teases present in the faeces, a second spiking experiment 
was set up. Ovotransferrin was spiked in two faecal sam-
ples from different birds. However, before spiking a pro-
tease inhibitor cocktail (Sigma-Aldrich, P2714; inhibits 
serine, cysteine and metallo-proteases) was either or not 
added to the ovotransferrin. The samples were incubated 
for 0, 2 or 24 h at room temperature. Protein extraction 
and ELISA were performed as described above and the 
pH was measured after different incubation periods. The 
% recovery of ovotransferrin at each timepoint was calcu-
lated relative to the 0 h timepoint.
Statistical analysis
Normality of the data was tested with the D’Agostino-
Pearson normality test. For the proteomic analysis of 
samples from the NE in  vivo trials, a Fisher’s exact test 
was performed on the total spectral counts of the sam-
ples from non-challenged birds or the samples from birds 
with lesion score 3–4. Hochberg–Benjamini correction 
was performed to correct for multiple testing. Differ-
ences in ovotransferrin levels between necrotic enteritis 
severity groups (as measured by ELISA) were calculated 
using an a Kruskal–Wallis test, followed by Dunn’s post 
hoc test. Differences in ovotransferrin levels between 
the Eimeria-challenged and the non-challenged control 
group were calculated using a Mann–Whitney test. The 
Spearman rank correlation was used to assess the rela-
tionship between the ovotransferrin concentration in 
the faecal samples and either the necrotic enteritis lesion 
score or the coccidiosis score. Results were reported as 
means and standard error of the means (SEM).
Results
Proteomic analysis and identification of differentially 
expressed proteins in necrotic enteritis samples
A total of 355,641 spectra were generated during the 
collection of MS/MS data from ten samples: five sam-
ples from birds that did not receive C. perfringens chal-
lenge (neg. ctrl) and five chickens with a lesion score 3–4. 
Using the NCBI non-redundant protein database 111,054 
spectra (99.0% minimum, 0.01% decoy FDR) were iden-
tified. These peptides could be assigned to 1099 (99.9% 
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minimum, 2 # peptides, 0.1% decoy FDR) proteins. Pro-
teins sharing significant peptide evidence were grouped 
into protein clusters, and 707 protein clusters were 
detected.
Of these proteins, 155 were in common, 288 proteins 
unique for the samples from non-challenged birds and 
500 proteins unique for the fraction with lesion score 
3–4. 137 proteins were statistically more abundant in the 
samples from diseased birds. 60 proteins were present 
in 4 or more samples from birds suffering from necrotic 
enteritis.
Among the proteins that were more abundant in 
challenged birds was ovotransferrin. This protein was 
detected in all five samples from birds suffering from 
necrotic enteritis with an average spectrum count of 128. 
Additionally, ovotransferrin could be detected in 4 out of 
5 samples from the non-challenged birds with an average 
spectrum count of 25. Therefore, there was an increased 
presence (p < 0.0001) of ovotransferrin in samples from 
birds suffering from necrotic enteritis.
Faecal ovotransferrin concentration correlates 
with the severity of necrotic enteritis
To confirm the results from the proteome analysis, an 
ovotransferrin ELISA was performed on samples from 
an independent NE in vivo trial. Most samples from birds 
suffering from either mild necrotic enteritis (score 2) or 
without intestinal lesions (both challenged and non-chal-
lenged control animals) showed a low signal. In samples 
from birds with more severe necrotic enteritis (necrosis 
score ≥ 3), significantly more ovotransferrin was detected 
than in samples from challenged birds that did not show 
intestinal disease (score 0) (Figure 1). Furthermore, there 
was a positive correlation between the necrotic enteri-
tis disease severity and the ovotransferrin concentration 
in the faecal samples from the NE in  vivo trial (n = 40, 
Spearman correlation coefficient = 0.53, p = 0.0004). This 
is not reflected in the litter samples from the NE trial, as 
no ovotransferrin could be detected in these samples.
Ovotransferrin levels in the faeces correlate 
with the severity of coccidiosis
A challenge trial with different Eimeria species was used 
as a second model for gut barrier failure. The ovotransfer-
rin levels in samples from Eimeria-challenged birds were 
elevated as compared to the non-challenged controls as 
measured by ELISA (p = 0.0029). Furthermore, there was 
a positive correlation between the coccidiosis score and 
the ovotransferrin concentration in the faeces (n = 20, 
Spearman correlation coefficient = 0.57, p = 0.0082). This 
difference in ovotransferrin levels was also reflected in 
the litter samples, where significantly higher ovotransfer-
rin levels were detected in litter from Eimeria-challenged 
birds as compared to litter samples from non-challenged 
control groups (p = 0.0043) (Figure 2).
Ovotransferrin is rapidly degraded by proteases 
in the faeces
To address the stability of ovotransferrin in the faeces, 
ovotransferrin was spiked in two independent pools of 
faecal material originating from healthy broilers. The 
spiked samples were incubated at room temperature for 
different time intervals, leading to a gradual decrease 
of the ovotransferrin signal as measured by ELISA. The 
decline in ovotransferrin was similar for both pools of 
faecal material (Figure  3A). Neutralization of the pro-
teases present in the faeces by addition of protease 
inhibitor cocktail increased the ovotransferrin stability 
in the faeces (Figure  3B). When no protease inhibitors 
were added to the pooled faecal content, only 51.29% of 
the ovotransferrin could be recovered after 2  h incuba-
tion, which decreased to a recovery of 20.36% after 24 h 
incubation. Addition of protease inhibitors increased the 
ovotransferrin recovery to 80.26% or 64.17% after 2  or 
24 h incubation at room temperature, respectively.
Figure 1 Ovotransferrin concentrations in the faeces from 
birds derived from a necrotic enteritis in vivo trial. The graph 
represents the ovotransferrin concentration measured by ELISA 
(mean ± standard error of the means) in faeces from birds that 
received all predisposing factors but were not challenged with 
C. perfringens (neg. ctr; n = 8) or from birds challenged with C. 
perfringens resulting in varying degrees of necrotic enteritis: no 
necrotic lesions (score 0; n = 8); mild intestinal necrosis (score 2; 
n = 8); moderate necrotic enteritis (score 3–4; n = 8) or severe 
necrosis (score 5–6; n = 8). *p < 0.05.
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Discussion
A well-functioning and healthy gut is essential to ensure 
good broiler welfare and performance. Enteric diseases 
that affect the structural integrity of the gastrointesti-
nal tract seriously affect bird performance, leading to 
economic losses. The availability of biomarkers for gut 
barrier failure would be of great value for the broiler 
industry (see Gilani et  al. [10] and Ducatelle et  al. [22] 
for a review). Faecal biomarkers for intestinal health 
are routinely used in human medicine as a preliminary 
screening tool and as an indicator of the severity of intes-
tinal mucosal damage [15]. In birds, previous research 
mainly focussed on the detection of markers in blood 
and therefore no faecal markers were yet described to 
detect increased intestinal permeability caused by enteric 
diseases.
Ovotransferrin is an iron-binding glycoprotein that 
is synthesized both in the liver and the oviduct, which 
exhibits antimicrobial activity that can partially be attrib-
uted to its ability to bind and sequester iron  (Fe3+), essen-
tial for bacterial growth [23]. Furthermore the 92-amino 
acid ovotransferrin peptide, OTAP-92, is capable of kill-
ing Gram-negative bacteria through membrane damag-
ing mechanisms [24]. Ovotransferrin acts as an acute 
phase protein (APP) in birds [23, 25]. Acute phase pro-
teins are blood proteins mainly produced in the liver, 
when triggered by different stimuli including trauma, 
infection, stress, neoplasia and inflammation (see Cray 
et al. for a review [26]). Changes in the circulating levels 
of APPs have been used as non-specific markers indica-
tive of the health status in humans and animals. Indeed, 
serum ovotransferrin was previously described as a 
marker of infection and inflammation in chickens [14, 23, 
25]. Moreover, ovotransferrin remains elevated as long 
as the inflammation persists, acting as immunomodula-
tor and preventing microbial growth [23, 27, 28]. Chicken 
ovotransferrin can be classified as a moderate APP 
Figure 2 Ovotransferrin concentrations in faecal and litter 
samples from experimental Eimeria‑infected and control birds. 
The graph represents the ovotransferrin concentration measured by 
ELISA (mean ± standard error of the means) in faeces (grey) or mixed 
litter (white) from experimental Eimeria-infected birds (coccidiosis; 
individual faeces samples: n = 10 or mixed litter samples: n = 6) or 
non-challenged control birds (neg. ctr; individual faeces: n = 10 
or mixed litter samples: n = 5). Significant differences between 
the coccidiosis group and the non-challenged control group are 
indicated with **p < 0.01.
Figure 3 Ovotransferrin stability in faeces from birds. The ovotransferrin stability in the faeces was assessed by spiking two independent 
faeces pools from healthy birds with ovotransferrin at a final concentration of 200 µg/g. A The spiked samples were aliquoted and incubated at 
room temperature for 0, 1, 2, 6 or 24 h after which the ovotransferrin concentration was measured by ELISA. B The ovotransferrin stability in the 
faeces with (black) or without (grey) the addition of protease inhibitors was assessed after 0, 2 or 24 h incubation at room temperature. The % 
ovotransferrin recovery was calculated relative to the 0 h timepoint.
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(one- to tenfold increase in circulating levels) [26]. Mod-
erate APPs generally show prolonged increases, relatively 
slow declines and may be particularly associated with 
chronic inflammatory processes. Chen et al. [12] recently 
described a set of biomarkers to evaluate gut barrier fail-
ure in broiler chickens, which included the measurement 
of the APP α1-acid glycoprotein in serum. However, 
elevated circulating APP levels are likely not specific for 
gut barrier failure, as other, non-gastrointestinal diseases 
with inflammation can cause an increase in serum APPs 
as well [14, 15]. As an example, although elevated circu-
lating ovotransferrin levels were previously measured in 
experimentally induced coccidiosis, this was also the case 
after pulmonary E. coli infection and vitiligo (an autoim-
mune-autoinflammatory disease), which are non-gastro-
intestinal diseases [25]. The measurement of markers in 
the faeces is likely more accurate in determining gut bar-
rier failure.
In this study, faecal ovotransferrin was identified as a 
marker for gut barrier failure in broiler chickens. Indeed, 
elevated faecal ovotransferrin levels were measured in 
birds with either experimental coccidiosis or necrotic 
enteritis, which both cause intestinal gut barrier fail-
ure, using different approaches. First, proteome analy-
sis of samples from different NE in  vivo trials revealed 
that ovotransferrin was more abundant in samples from 
birds suffering from necrotic enteritis as compared to 
non-challenged birds. These results were confirmed via 
ELISA on samples from another, independent, NE in vivo 
trial. Additionally, elevated ovotransferrin concentra-
tions were measured by ELISA in samples from Eimeria-
infected birds as compared to their non-challenged 
controls. Faecal ovotransferrin levels were significantly 
correlated with the severity of gut barrier failure caused 
by either coccidiosis or necrotic enteritis, indicating 
that faecal ovotransferrin measurement might represent 
a valuable tool to measure gut barrier failure caused by 
enteric diseases. However, there was quite some varia-
tion in absolute ovotransferrin levels measured between 
the coccidiosis and NE in vivo experiments. In order to 
be used as a maker in the field, further research is needed 
to determine the ovotransferrin levels in the faeces from 
healthy as well as diseased birds under field conditions. 
Meanwhile, the measurement of ovotransferrin already 
represents an interesting tool to measure gut barrier fail-
ure under experimental settings, as it can assess efficacy 
of molecules or strategies that reduce intestinal disease.
Loss of plasma proteins into the gastro-intestinal 
tract is a well-known complication of a variety of 
enteric disorders which are associated with widespread 
loss of intestinal barrier integrity [29]. The proteome 
analysis revealed low levels of ovotransferrin in faeces 
of non-challenged birds. This is in accordance with a 
recent study of Marques et  al. [30], showing low lev-
els of ovotransferrin expression in epithelium and 
endothelium of the intestinal tract of healthy chick-
ens. A wide range of infectious and non-infectious 
agents are known to damage the intestinal barrier in 
chickens, leading to gastrointestinal leakage and poor 
performance. Mild intestinal barrier damage will lead 
to reduced integrity of the epithelial layer, with conse-
quent loss of fluid and ions towards the intestinal lumen 
[10]. More severe intestinal barrier damage will lead to 
translocation of micro-organisms and toxins from the 
intestinal lumen into the blood stream [31]. This trans-
location, together with the release of pro-inflammatory 
cytokines from the local inflammatory response in the 
gut, may trigger an acute phase response in the liver. 
The severe permeability defects in the gut epithelium 
may allow leakage of the APPs from the circulation into 
the gut lumen. This may explain why ovotransferrin is 
increased in the faeces only in case of widespread and 
severe intestinal barrier damage and was not elevated 
in samples from birds showing mild necrotic enteritis.
In order to be of value in the broiler industry, a 
marker should be detectable and predictive at flock 
level and not only at the level of the individual bird. 
Indeed, ovotransferrin could be detected in mixed litter 
samples from coccidiosis-challenged birds, whereas no 
ovotransferrin was measured in the litter from the con-
trol groups. However, no ovotransferrin was detected 
in the litter from the challenged birds in the necrotic 
enteritis trial. This might be attributed to the overall 
lower ovotransferrin levels measured in samples from 
the necrotic enteritis trial as compared to the coc-
cidiosis trial, resulting in less ovotransferrin in the lit-
ter material. Additionally, ovotransferrin was rapidly 
degraded by proteases in the faeces, indicating that 
only relatively fresh material can be used for the assess-
ment of gut barrier failure by measuring this marker. In 
order to circumvent this degradation problem, future 
research might focus on other, more stable APPs such 
as alpha-1 antitrypsin inhibitor protein, which is resist-
ant to bacterial degradation or the effects of digestive 
enzymes within the gut lumen [32, 33].
In conclusion, the detection of ovotransferrin in the 
faeces represents an interesting strategy to measure gut 
barrier failure in poultry. Further research is needed to 
elucidate whether ovotransferrin release in faeces can 
be detected in other intestinal disease conditions in 
chickens and on the use of this faecal biomarker under 
field conditions.
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